There were more poor prognostic deletions in the tumor characterization functional category (e.g., MUC4 and PTPRN2 gene deletions) and better prognostic deletions in the lymphocyte regulation functional category (Fig. 5b). This evidence concerns the gene MUC4 and neoplasm.